Inactief instrument

Koers Biondvax Pharmaceuticals Ltd

Aandelen

slotkoers TEL AVIV STOCK EXCHANGE Andere beurzen
- ^ILa	-

Biondvax Pharmaceuticals : Announces Rights Offering Fully Subscribed at US$20 Million	16-07-19
Biondvax Pharmaceuticals : First Participant Enrolled in Second Cohort of BiondVax’s Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine Trial	08-07-19
Biondvax Pharmaceuticals : European Investment Bank VP attends Signature Event at BiondVax Extending Financing Agreement with BiondVax to €24 million	26-06-19
Biondvax Pharmaceuticals : Patent Covering Manufacturing Process of BiondVax’s M-001 Universal Flu Vaccine Allowed in USA and Japan	18-06-19
Biondvax Pharmaceuticals : Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial of the M-001 Universal Flu Vaccine and Scale Up of Manufacturing Process	10-06-19

Managers	Titel	Leeftijd	Van
Amir Reichman CEO	Chief Executive Officer	49	02-03-21
Uri Ben-Or DFI	Director of Finance/CFO	52	01-01-07
Dalit Weinstein Fischer CTO	Chief Tech/Sci/R&D Officer	-	01-01-22

Besturend	Titel	Leeftijd	Van
Adi Raviv BRD	Director/Board Member	69	24-03-20
Samuel Moed BRD	Director/Board Member	62	24-03-20
Morris Laster BRD	Director/Board Member	59	27-11-17

Sector

	Vaira. 1 jan.	Kapi.
IQVIA HOLDINGS INC.	+4,09%	43,43 mld.
LONZA GROUP AG	+47,81%	41,69 mld.
MODERNA, INC.	+9,45%	41,31 mld.
CELLTRION, INC.	-10,92%	27,14 mld.
ICON PUBLIC LIMITED COMPANY	+9,32%	25,28 mld.
ALNYLAM PHARMACEUTICALS, INC.	-24,87%	18,47 mld.
MEDPACE HOLDINGS, INC.	+29,70%	12,59 mld.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1,28%	12,33 mld.
UNITED THERAPEUTICS CORPORATION	+7,78%	11,03 mld.